Found 4 cases where Vaccine is COVID19 and FLUN3

Administered by: Unknown       Purchased by: ?
Symptoms: Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: USAstraZeneca2021A427973

Write-up: HIVES AFTER ADMINISTRATION OF NASAL FLUMIST; A spontaneous report has been received from a consumer. The report concerns a male patient (age not provided). No medical history was reported. No concomitant products were reported. On an unknown date, the patient received Flumist (influenza vaccine) once/single administration, via nasal route. The patient started treatment with Covid Vaccine (covid-19 vaccine) on an unknown date. A Unknown administered FLUMIST. No malfunction has been reported for this combination product. On an unknown date, the patient experienced hives after administration of nasal flumist (preferred term: Urticaria). It was unknown if any action was taken with Flumist and Covid Vaccine. The outcome of the event hives after administration of nasal flumist was unknown. The event was considered non-serious. The reporter assessed the event hives after administration of nasal flumist as non-serious. Device Information: Combination Product Report: Yes Product As Reported: FLUMIST Common Device Name: Nasal Spray Product Role: Suspect

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Pallor, Vomiting
SMQs:, Acute pancreatitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-10-14
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up:

Administered by: Other       Purchased by: ?
Symptoms: Off label use, Product use issue, Seizure
SMQs:, Torsade de pointes/QT prolongation (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Medication errors (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CAPFIZER INC202300028711

Write-up: Seizure; Off label use; Product use for unapproved combination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Regulatory Authority. Regulatory number: E2B_05933798 (RA). Other Case identifier(s): 2022A317960 (RA). A male patient received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine live reassort 3v (FLUMIST), (Batch/Lot number: unknown) for immunisation; varicella zoster vaccine live (VARICELLA ZOSTER VACCINE LIVE), (Batch/Lot number: unknown) for immunisation. The patient''s relevant medical history and concomitant medications were not reported. The following information was reported: SEIZURE (hospitalization, medically significant, life threatening), outcome "unknown"; OFF LABEL USE (non-serious), outcome "unknown"; PRODUCT USE ISSUE (non-serious), outcome "unknown", described as "Product use for unapproved combination ". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Administered by: Unknown       Purchased by: ?
Symptoms: Off label use, Seizure
SMQs:, Torsade de pointes/QT prolongation (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Prophylaxis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CA0095075132301CAN008457

Write-up: seizure; off label use; This spontaneous report has benn received from Agency (Adverse reaction report number E2B_05933798) and refers to a male patient of unknown age The patient''s concurrent condition, medical history and concomitant terapies were not provided. On an unknown date ,the patient was vaccinated with zoster vaccine live(ZOSTAVAX II) (dose, strength, lot# and expiration date were not provided) for immunisation. The patient was also vaccinated with influenza vaccine live reassort 3v(FLUMIST) and tozinameran(BNT162B2) on unspecified date. On an unknown date, the patient experienced seizure (hospitalization, medically significant and life threatening) and off label use and was hospitalized on unspecified date. The outcome of seizure and off label use was unknown. The action taken was not applicable. The events were considered to be life-threatening and medically significant by the agency. The causal relationship between the evet seizure and zoster vaccine live(ZOSTAVAX II) was not provided.; Sender''s Comments: Reporter Comments:PVI (19-JAN-2023) SAE